ReviewItalian journal of pediatrics2022

Eligibility criteria for pediatric patients who may benefit from anti SARS-CoV-2 monoclonal antibody therapy administration: an Italian inter-society consensus statement.

Marcello Lanari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.